IBRX
NASDAQ · Biotechnology
Immunitybio Inc
$7.64
+0.32 (+4.37%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,324.0% upside
Low Target
$71.54
Average Target
$108.79
High Target
$142.95
Current Price
$7.64
Current
$7.64
$7.64
Target
$108.79
$108.79
$71.54
$108.79 avg
$142.95
Scenario Analysis
Bear Case
$71.54
836.4%
Low target
Base Case
$108.79
+1,324.0%
Avg target
Bull Case
$142.95
+1,771.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.43
-38.5% from high
52-Week Low
$1.95
+291.8% from low
50-Day SMA
$4.22
+81.0% vs SMA
200-Day SMA
$2.95
+159.0% vs SMA
RSI (14)
70.9
Overbought
Target vs 52W High
$108.79
+775.2% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.09
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |